一例接种MF59佐剂2009甲型H1N1大流行疫苗受试者的季节性抗体库分析
该研究对一项临床试验中7名接种MF59佐剂单价2009甲型H1N1疫苗受试者中的1人,在接种前及接种后8、22、202天采集全血,重建并分析其纵向流感特异性循环B细胞库。对390个受试者来源抗体进行基因型分析,发现使用29个免疫球蛋白重链可变区(IgHV)胚系基因,早期应答由两个主要谱系主导;体外表型分析显示抗体结合血凝素(HA)和神经氨酸酶(NA)上多种表位,许多为亚优势表位;非相关谱系间IgHV胚系使用与结合表位及中和广度强相关。结果提示抗体应答可能被错误导向疫苗病毒(CVV)上的鸡胚适应伪影,同时强调通过回忆亚优势记忆应答对多数新抗原产生强效广谱中和应答的能力,以及临床试验后评估替代终点检测和抗NA应答的必要性。
要点
- 对1名受试者390个抗体进行基因型分析,鉴定出29个IgHV胚系基因。
- 早期应答由两个主要谱系主导,多数序列代表记忆回忆应答。
- 非相关谱系间IgHV胚系使用与结合表位及中和广度强相关。
核心结论
- 抗体应答可能被错误导向CVV上的鸡胚适应伪影,同时可通过回忆亚优势记忆应答对多数新抗原产生强效广谱中和应答。
- 作者认为需要评估替代终点检测和临床试验后的抗NA应答。
研究设计与样本
- 该研究为一项临床试验中的7名受试者接种MF59佐剂单价2009甲型H1N1疫苗,疫苗由鸡胚传代候选疫苗病毒A/California/07/2009 X-181开发。
- 在接种前及接种后8、22、202天采集全血并评估血清学应答,本研究重建并分析其中1名受试者的纵向流感特异性循环B细胞库。
主要发现
- 对390个受试者来源抗体进行基因型分析,免疫球蛋白重链可变区(IgHV)共使用29个胚系基因,多数序列代表记忆回忆应答,两个主要谱系主导早期应答。
- 体外表型分析显示抗体结合血凝素(HA)和神经氨酸酶(NA)表面糖蛋白上多种表位,许多为亚优势表位。
- 非相关谱系间IgHV胚系使用与结合表位及中和广度呈强相关。
临床怎么用
- 作者认为需要评估替代终点检测和临床试验后的抗NA应答。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During the height of the 2009 H1N1 swine-derived influenza pandemic, a clinical trial was conducted in which seven subjects were immunized using a monovalent, MF59®-adjuvanted vaccine, developed from an egg-passaged candidate vaccine virus (CVV), A/California/07/2009 X-181. Whole blood was collected prior to immunization and at 8, 22, and 202 days post-vaccination, and subjects' serological responses were evaluated. Here, we reconstruct and examine the longitudinal, influenza-specific circulating B cell repertoire of one subject in that study. Genotypic analysis of 390 total subject-derived antibodies (Abs) revealed a total of 29 germline genes in use among immunoglobulin heavy chain variable regions (IgHV), with the majority of those sequences isolated representing memory recall responses and two major lineages dominating the early response. In vitro phenotyping showed a diverse set of binding epitopes on the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA), many of which are considered subdominant. Strong correlations were found between IgHV germline usage among non-related lineages and both binding epitope and neutralization breadth. Results here highlight the potential for Ab responses to be misdirected to egg-adaptive artifacts on CVVs while simultaneously stressing the ability to mount potent, broadly neutralizing responses to mostly novel antigens via recall of subdominant memory responses, as well as the need for evaluating alternative endpoint assays and anti-NA responses following clinical trials.
引用
- Ferdman J, Palladino G, Liao HX, et al. Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine. Vaccine. 2018. PMID: 30055967. doi:10.1016/j.vaccine.2018.06.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。